Evaluation of guide-free Cas9-induced genomic damage and transcriptome changes in pig embryos
Weikai Ge,Xiaozhu Zhao,Shixue Gou,Qin Jin,Fangbing Chen,Zhen Ouyang,Chengdan Lai,Tao Cui,Baoyi Mai,Sijia Lu,Kexin Zhong,Yanhui Liang,Tao Chen,Han Wu,Nan Li,Yinghua Ye,Liangxue Lai,Kepin Wang
DOI: https://doi.org/10.1016/j.omtn.2023.102035
IF: 10.183
2023-09-21
Molecular Therapy — Nucleic Acids
Abstract:Cas9 protein without sgRNAs can induce genomic damage at the cellular level in vitro . However, whether the detrimental effects occur in embryos after Cas9-treatment remains unknown. Here, using pig embryos as subjects, we observed that Cas9 protein transcribed from injected Cas9 mRNA can persist until at least the blastocyst stage. Cas9 protein alone can induce genome damage in preimplantation embryos, represented by the increased number of phosphorylated histone H2AX foci on the chromatin fiber, which led to apoptosis and decreased cell number of blastocysts. In addition, single-blastocyst RNA sequencing confirmed that Cas9 protein without sgRNAs can cause changes in the blastocyst transcriptome, depressing embryo development signal pathways, such as cell cycle, metabolism, and cellular communication-related signal pathways, while activating apoptosis and necroptosis signal pathways, which together resulted in impaired preimplantation embryonic development. These results indicated that attention should be given to the detrimental effects caused by the Cas9 protein when using CRISPR/Cas9 for germline genome editing, especially for the targeted correction of human pathological mutations using germline gene therapy.
medicine, research & experimental